Brokerages Anticipate LifePoint Health, Inc. (LPNT) Will Post Quarterly Sales of $1.60 Billion
Analysts expect that LifePoint Health, Inc. (NASDAQ:LPNT) will report $1.60 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have provided estimates for LifePoint Health’s earnings. The lowest sales estimate is $1.58 billion and the highest is $1.61 billion. LifePoint Health reported sales of $1.59 billion during the same quarter last year, which indicates a positive year over year growth rate of 0.6%. The company is expected to issue its next quarterly earnings report on Friday, October 27th.
On average, analysts expect that LifePoint Health will report full-year sales of $1.60 billion for the current fiscal year, with estimates ranging from $6.44 billion to $6.49 billion. For the next year, analysts anticipate that the company will report sales of $6.61 billion per share, with estimates ranging from $6.48 billion to $6.72 billion. Zacks’ sales calculations are an average based on a survey of research firms that that provide coverage for LifePoint Health.
LifePoint Health (NASDAQ:LPNT) last announced its quarterly earnings data on Tuesday, August 1st. The company reported $0.96 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.06. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. The business had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the company earned $0.69 earnings per share. LifePoint Health’s quarterly revenue was up .2% compared to the same quarter last year.
A number of equities analysts recently weighed in on LPNT shares. ValuEngine raised shares of LifePoint Health from a “hold” rating to a “buy” rating in a research note on Thursday, August 17th. BidaskClub lowered shares of LifePoint Health from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Zacks Investment Research raised shares of LifePoint Health from a “sell” rating to a “hold” rating in a research note on Monday, August 21st. Finally, Piper Jaffray Companies reaffirmed a “hold” rating and issued a $66.00 target price on shares of LifePoint Health in a research note on Wednesday. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $66.40.
In other LifePoint Health news, Chairman William F. Carpenter III sold 17,653 shares of the business’s stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the sale, the chairman now directly owns 439,841 shares of the company’s stock, valued at approximately $28,616,055.46. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 8.76% of the company’s stock.
Large investors have recently modified their holdings of the business. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in LifePoint Health by 10.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock worth $113,000 after buying an additional 164 shares in the last quarter. LS Investment Advisors LLC lifted its position in LifePoint Health by 43.7% during the 2nd quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock worth $120,000 after buying an additional 543 shares in the last quarter. US Bancorp DE lifted its position in LifePoint Health by 1.6% during the 1st quarter. US Bancorp DE now owns 1,931 shares of the company’s stock worth $127,000 after buying an additional 30 shares in the last quarter. Bank of Montreal Can lifted its position in LifePoint Health by 18.7% during the 1st quarter. Bank of Montreal Can now owns 1,946 shares of the company’s stock worth $128,000 after buying an additional 306 shares in the last quarter. Finally, Shelton Capital Management bought a new stake in LifePoint Health during the 2nd quarter worth about $205,000. 99.53% of the stock is currently owned by hedge funds and other institutional investors.
Shares of LifePoint Health (LPNT) traded down 0.09% during mid-day trading on Thursday, hitting $57.70. The company had a trading volume of 202,785 shares. The firm’s 50-day moving average price is $56.94 and its 200 day moving average price is $61.36. LifePoint Health has a one year low of $50.60 and a one year high of $70.95. The company has a market capitalization of $2.31 billion, a P/E ratio of 12.92 and a beta of 0.84.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.